Impact BioMedical Inc.
IBO | AMEX
$4.20
+$0.40 (+10.53%)
Nov 2, 2026, 1:16 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3K | 7K | 7K | 18K | 7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1K | n/a | 422K | 1K | 1K | n/a | n/a | n/a | 279K | 280K | 280K | 280K | 280K | 280K | 278K | 279K | 278K | 278K | 278K | 278.53K | 278.24K | 278.24K |
Gross Profit | 2K | 7K | -415K | 17K | 6K | n/a | n/a | n/a | -279K | -280K | -280K | -280K | -280K | -280K | -278K | -279K | -228K | -278K | -278K | -278.53K | -278.24K | -278.24K |
Operating Income | -702K | -2.29M | -1.16M | -948K | -1.15M | -1.01M | -26.23M | -1.13M | -626K | -771K | -1.14M | -1.08M | -1.01M | -819K | -1.04M | -889K | -750K | -709K | -1.07M | -778.25K | -634.12K | -698.63K |
Interest Income | 2K | 5K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 90K | 96K | 82K | 56.15K | 25.77K | 1.08K |
Pretax Income | -700K | -2.28M | 2.66M | -1.48M | -14.35M | -1.28M | -27.1M | 4.24M | -884K | -998K | -1.26M | -1.18M | -1.12M | -849K | -5.42M | -978K | -799K | -746K | -1.11M | -920.47K | -512.22K | -698.31K |
Net Income | -699K | -2.29M | 5.25M | -1.47M | -14.35M | -1.27M | -27.11M | 4.25M | -889K | -962K | -1.24M | -1.16M | -1.1M | -657K | -3.53M | -2.17M | -732K | -669K | 318K | -805.42K | -335.33K | -480.25K |
Selling & General & Admin | 277K | 1.9M | 275K | 516K | 676K | 509K | 591K | 719K | 347K | 308K | 396K | 559K | 462K | 360K | 240K | 280K | 316K | 263K | 361K | 310.02K | 144.5K | 176.48K |
Research & Development | 76K | 46K | 110K | 52K | 75K | 103K | -108K | 82K | n/a | 183K | 463K | 239K | 266K | 179K | 522K | 330K | 206K | 168K | 435K | 189.7K | 211.38K | 243.91K |
Other Expenses | 351K | 352K | 358K | 397K | 408K | 398K | 25.75M | 326K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 704K | 2.3M | 743K | 965K | 1.16M | 1.01M | 26.23M | 1.13M | 347K | 491K | 859K | 798K | 728K | 539K | 762K | 610K | 522K | 431K | 796K | 499.72K | 355.88K | 420.4K |
Interest Expense | n/a | n/a | n/a | 262K | 260K | 271K | 270K | 305K | 261K | 230K | 125K | 102K | 116K | 101K | 329K | 92K | 139K | 133K | 122K | 178K | n/a | n/a |
Selling & Marketing Expenses | 185K | 1K | 2K | 2K | 1K | 19K | 146K | 461K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 705K | 2.3M | 1.17M | 966K | 1.16M | 1.01M | 26.23M | 1.13M | 626K | 771K | 1.14M | 1.08M | 1.01M | 819K | 1.04M | 889K | 800K | 709K | 1.07M | 778.25K | 634.12K | 698.63K |
Income Tax Expense | n/a | n/a | -2.58M | n/a | n/a | n/a | 33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.88M | 1.26M | n/a | n/a | -1.17M | -100 | -87.2K | -140.7K |
Shares Outstanding (Basic) | 8.54M | 8.54M | 2.5M | 965.56K | 965.56K | 955.84K | 911.97K | 5.71M | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K |
Shares Outstanding (Diluted) | 8.54M | 8.54M | 2.5M | 965.56K | 965.56K | 955.84K | 911.97K | 5.71M | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K |
EPS (Basic) | -0.08 | -0.27 | 0.63 | -1.51 | -14.89 | -1.26 | -29.78 | 4.67 | -0.98 | -1.06 | -1.39 | -1.26 | -1.21 | -0.72 | -3.91 | -2.40 | -0.80 | -0.73 | 0.35 | -0.88 | -0.37 | -0.53 |
EPS (Diluted) | -0.08 | -0.27 | 0.63 | -1.51 | -14.89 | -1.26 | -29.78 | 0.76 | -0.98 | -1.06 | -1.39 | -1.26 | -1.21 | -0.72 | -3.91 | -2.40 | -0.80 | -0.73 | 0.35 | -0.88 | -0.37 | -0.53 |
EBITDA | -418K | -2M | 2.94M | -925K | -13.8M | -724K | -26.55M | 4.83M | -347K | -491K | -859K | -798K | -728K | -539K | -762K | -610K | -472K | -431K | -796K | -499.72K | -355.88K | -420.4K |
EBIT | -702K | -2.28M | 2.66M | -1.21M | -14.09M | -1.01M | -26.83M | 4.55M | -626K | -771K | -1.14M | -1.08M | -1.01M | -819K | -1.04M | -889K | -750K | -709K | -1.07M | -778.25K | -634.12K | -698.63K |
Depreciation & Amortization | 284K | 285K | 286K | 288K | 288K | 283K | 279K | 281K | 279K | 280K | 280K | 280K | 280K | 280K | 278K | 279K | 278K | 278K | 278K | 278.53K | 278.24K | 278.24K |
Add to Watchlist
Select watchlists to add or remove IBO